パロモマイシン
IUPAC | |
---|---|
| |
Catenulin, Aminosidine, others[2] | |
Drugs.com | monograph |
MedlinePlus | a601098 |
| |
| |
By mouth, intramuscular, topical[1] | |
Poorly absorbed in the GI tract | |
Not available | |
Fecal | |
CAS | 1263-89-4 |
ATCコード |
A07AA06 (WHO) QJ01GB92 (WHO) |
PubChem | CID: 441375 |
DrugBank | DB01421 |
ChemSpider | 390117 |
ChEBI | CHEBI:7934 |
ChEMBL | CHEMBL370143 |
monomycin, aminosidine[3] | |
C23H47N5O18S | |
615.629 g/mol | |
| |
|
パロモマイシン(Paromomycin)はアメーバ
パロモマイシンは1950
出典
[- ^ a b c d e f g h i “Paromomycin Sulfate”. The American Society of Health-System Pharmacists. 17 November 2016
時 点 のオリジナルよりアーカイブ。3 December 2016閲覧 。 - ^ a b Publishing, William Andrew (2013) (
英語 ). Pharmaceutical Manufacturing Encyclopedia, 3rd Edition (3 ed.). Elsevier. p. 21p. ISBN 9780815518563. オリジナルの2016-12-20時点 におけるアーカイブ。 - ^ “Aminosidine ointments for the treatment of experimental cutaneous leishmaniasis”. Transactions of the Royal Society of Tropical Medicine and Hygiene 88 (2): 223–5. (1994). doi:10.1016/0035-9203(94)90307-7. PMID 8036682.
- ^ a b c “Paromomycin”. Transactions of the Royal Society of Tropical Medicine and Hygiene 103 (7): 653–60. (2008). doi:10.1016/j.trstmh.2008.09.008. PMID 18947845.
- ^ “WHO Model List of Essential Medicines (19th List)”. World Health Organization (April 2015). 13 December 2016
時 点 のオリジナルよりアーカイブ。8 December 2016閲覧 。 - ^ a b Hamilton, Richart (2015). Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition. Jones & Bartlett Learning. p. 54. ISBN 9781284057560